Pharmaceutical

Filter

Current filters:

None

Popular Filters

6750 to 6774 of 6948 results

Shire drops Dermagraft for venous leg ulcers, after Ph III failure

25-08-2011

Ireland-headquartered drugmaker Shire (LSE: SHP) says that Advanced BioHealing (ABH), the USA-based regenerative…

Advanced BioHealingBiotechnologyDermagraftDermatologicalsPharmaceuticalRegulationResearchShire

Cambridge, UK, spin-out MISSION Therapeutics gets £6 million funding

25-08-2011

A team led by Stephen Jackson together with the UK’s Cancer Research Technology (Cancer Research…

EuropeFinancialMISSION TherapeuticsOncologyPharmaceuticalResearch

Jordan’s Hikma delivers 10.4% sales growth in first half 2011

25-08-2011

Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) has reported interim results for the six months…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Allergan gets US FDA nod for Botox to treat form of urinary incontinence

25-08-2011

There was a boost for US specialty drug firm Allergan (NYSE: AGN) yesterday when the company revealed…

AllerganBotoxNeurologicalNorth AmericaPharmaceuticalRegulation

Spain hopes to save 2.4 billion euros by ordering doctors to Rx generics

25-08-2011

As part of moves to reduce the nation’s budget deficit, Spain’s socialist government has passed…

EuropeFinancialGenericsLegalPharmaceuticalRegulation

US govt tightens financial conflict of interest rules for medical researchers

25-08-2011

The US Department of Health and Human Services this week issued an updated Final Rule on conflict of…

FinancialNorth AmericaPharmaceuticalRegulationResearch

Diabetes treatments now 8.4% of UK annual NHS drugs bill, says report

24-08-2011

Diabetes prescriptions now account for 8.4 per of the entire National Health Service net bill for primary…

DiabetesEuropeHealthcareMarkets & MarketingPharmaceuticalPricing

UAE pharmaceutical industry set to benefit from lifestyle changes

24-08-2011

A recent Dubai Chamber of Commerce and Industry study indicates that the United Arab Emirates (UAE) pharmaceutical…

GenericsHealthcareMarkets & MarketingPharmaceuticalRest of the World

Trudeau Institute discovers how FluMist elicits protection

24-08-2011

New research from the USA-based Trudeau Institute may help to explain why live attenuated influenza vaccine…

Anti-viralsAstraZenecaFluMistPharmaceuticalResearchVaccines

Slow growth forecast for asthma therapeutics market to 2018

24-08-2011

The global asthma therapeutics market was valued at $14.4 billion in 2010, and is forecast to grow at…

Markets & MarketingPharmaceuticalResearchRespiratory and Pulmonary

AstraZeneca breast cancer drug Faslodex not good use of NHS resources, says NICE draft guidance

24-08-2011

An independent committee of experts that develops guidance on behalf of the UK drugs watchdog the National…

AstraZenecaEuropeFaslodexOncologyPharmaceuticalPricingRegulation

CEL-SCI in deal to market Multikine in Argentina and Venezuela

24-08-2011

US drug developer CEL-SCI Corp (NYSE AMEX: CVM) has entered into an exclusive sales, marketing and distribution…

BiotechnologyCEL-SCI CorpIDC-GP PharmLicensingOncologyPharmaceuticalSouth America

Changing the mood of Brazilian antidepressant market; fake Levitra

24-08-2011

The Vice President of Brazil’s Superior Court of Justice (STJ), Minister Felix Fischer, has restored…

BayerGenericsLevitraLexaproLundbeckNeurologicalPharmaceuticalRegulationReproductiveSouth America

USA’s Public Citizen calls for strongest warnings on PPIs, saying they are over-Rxed

23-08-2011

In a petition sent to the US Food and Drug Administration yesterday, consumer advocacy group Public Citizen…

Gastro-intestinalsNorth AmericaPharmaceuticalRegulation

Santarus and Depomed expand US deal on Glumetza

23-08-2011

US drugmakers Santarus (Nasdaq: SNTS) and Depomed (Nasdaq: DEPO) have entered into a new commercialization…

DepomedDiabetesGlumetzaLicensingNorth AmericaPharmaceuticalSantarus

US FDA fast-tracks Bayer and Algeta’s prostate drug Alpharadin

23-08-2011

Germany’s Bayer (BAY: DE) said this morning that its investigational compound Alpharadin (radium-223…

AlgetaAlpharadinBayerNorth AmericaOncologyPharmaceuticalRegulation

AstraZeneca blood thinner Brilinta now available in USA

23-08-2011

Anglo-Swedish pharmaceutical major AstraZeneca (LSE: AZN) said yesterday that Brilinta (ticagrelor) tablets,…

AstraZenecaBrilintaCardio-vascularMarkets & MarketingNorth AmericaPharmaceutical

Nycomed to market Norgine’s laxative MoviPrep in Russia and CIS

23-08-2011

Swiss independent drugmaker Nycomed and Netherlands-headquartered Norgine, have entered into a licensing…

EuropeGastro-intestinalsLicensingMarkets & MarketingMoviPrepNorgineNycomedPharmaceutical

6750 to 6774 of 6948 results

Back to top